(Q87202944)

English

Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-te

scientific article published on 31 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

1 reference

based on heuristic

inferred from title

author name string

Liang Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Wei-da Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Zhong-jun Xia

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Yu-jing Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jin Xiang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Yue Lu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

31 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

860

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481637%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

https://scigraph.springernature.com/pub.10.1007/s12032-014-0860-4

0 references

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective apoptosis of natural killer-cell tumours by l-asparaginase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q87202944&oldid=1567990221"